Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Serum Endocan Levels in Patients With Gestational Diabetes

NCT05237895 is registered in ClinicalTrials.gov with Gaziosmanpasa Research and Education Hospital as lead sponsor.

NCT NCT05237895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05237895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Serum Endocan Levels in Patients With Gestational Diabetes
Lead sponsor
Gaziosmanpasa Research and Education Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 3, 2022
Completion date
May 5, 2022
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endocan, gestational diabetes